keyboard_arrow_up

Community Acquired Pneumonia Clinical Trials Market Review H2 2014

“Community Acquired Pneumonia Global Clinical Trials Review, H2, 2014″ provides data on the Community Acquired Pneumonia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Community Acquired Pneumonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Community Acquired Pneumonia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

List of Tables

Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Region, 2014* 7

Community Acquired Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8

Community Acquired Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9

Community Acquired Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10

Community Acquired Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11

Community Acquired Pneumonia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12

Community Acquired Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13

Community Acquired Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14

Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15

Community Acquired Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16

Community Acquired Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17

Proportion of Community Acquired Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18

Community Acquired Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19

Community Acquired Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20

Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Phase, 2014* 21

Community Acquired Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22

Community Acquired Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23

Community Acquired Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24

Community Acquired Pneumonia Therapeutics, Global, Suspended Clinical Trials, 2014* 25

Community Acquired Pneumonia Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25

Community Acquired Pneumonia Therapeutics, Global, Terminated Clinical Trials, 2014* 26

Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27

Community Acquired Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28

Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29

Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30

Community Acquired Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31

Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 33

Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by TaiGen Biopharmaceuticals Holdings Limited, 2014* 35

Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 36

Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014* 37

Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 38

Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Melinta Therapeutics, Inc, 2014* 39

Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 40

Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 41

Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 42

Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 43

Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Antonius Hospital, 2014* 44

Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014* 45

Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Milan, 2014* 46

Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by HaEmek Medical Center, 2014* 47

Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical Center Alkmaar, 2014* 48

Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Spanish National Health System, 2014* 49

Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Carlos III Health Institute, 2014* 50

Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagasaki Evaluation Organization for Clinical Interventions, 2014* 51

Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ono Municipal Hospital, 2014* 52

Community Acquired Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Roma La Sapienza, 2014* 53

To get Discount on this report, visit: http://www.rnrmarketresearch.com/contacts/discount?rname=247104 .

This is a premium report priced at US$2500 for a single user PDF.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

·         Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

·         Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

·         Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

·         Understand the dynamics of a particular indication in a condensed manner

·         Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

·         Obtain discontinued trial listing for trials across the globe

·         Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies